Intermacs is a North American registry for the clinical outcomes of patients who receive an FDA-approved mechanical circulatory support device to treat advanced heart failure.

The 14th Annual Report from The Society of Thoracic Surgeons (STS) Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs) describes outcomes of 27,493 patients with a …

Purpose: INTERMACS scale is considered a valid score system to stratify patients’ risk profile in terms of morbidity and mortality after mechanical circulatory support (MCS). This might be a particularly …

The twelfth annual report from The Society of Thoracic Surgeons (STS) Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs) highlights outcomes for 26 688 continuous …

However, in order to classify the patients more precisely, seven Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) patient profiles with three modifiers were created...

Intermacs® 1: Critical cardiogenic shock describes a patient who is “crashing and burning”, in which a patient has life-threatening hypotension and rapidly escalating inotropic pressor support, with critical …

Background Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) patient profiles and modifiers are descriptors of patient illness severity before durable ventricular assist …

El objetivo del presente estudio es analizar la utilidad de la escala INTERMACS para estratificar el pronóstico postoperatorio de los pacientes con IC avanzada que reciben un TrC urgente. Tabla 1.

Sep 1, 2018 · INTERMACS is a North American registry established in 2005 for patients who are receiving MCS for advanced HF (5). Within INTERMACS profiles, patients are divided by their signs …

We present detailed descriptions of morbidity and mortality associated with VAD support, using standard Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) criteria for …